Healthcare stocks gained Friday afternoon, with the NYSE Healthcare Index rising 1.1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.5%.
In corporate news, shares of Moderna (MRNA) and other vaccine developers rose after The New York Times reported that the US National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares jumped 11%. Merck (MRK), Novavax (NVAX) and BioNTech (BNTX) shares were up 2.4%, 13% and 4.9%, respectively. Vaxcyte (PCVX) and Vir Biotechnology (VIR) shares popped 8.5% and 6.3%, respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.